Direct-to-Consumer Advertising of Pharmaceuticals

Guest article by Ray Collins The FDA has tolerated, regulated, and now seems to favor direct-to-consumer advertising by pharmaceutical companies, apparently as part the the judicial and regulatory trends toward corporate free speech. Susan Schwartz McDonald…

Innovating Healthcare is Hard

  I added this comment to Innovating Healthcare is Hard, an article on MedCrunch by Eugene Borukhovich. DISRUPTIVE innovation is especially hard, because entrenched stakeholders stand to lose lots of money if things change. Even though there’s…